stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Raia Drogasil S.A.

Brazil Β· B3:Β RADL3.SA Β· Market cap: Β· P/E: Β· P/S:

Raia Drogasil runs a huge chain of pharmacy stores across Brazil, selling medicines, cosmetics, and personal care products to everyday shoppers.

Raia Drogasil is Brazil's biggest pharmacy chain. It runs thousands of stores under two main brands β€” Droga Raia and Drogasil β€” and fills prescriptions, sells over-the-counter medicines, and stocks shelves with cosmetics, shampoo, vitamins, and the small everyday health items people reach for. If you live in a Brazilian city, there is a good chance one of its green-and-white or blue-and-yellow storefronts is a short walk away.

Raia Drogasil S.A. (RADL3.SA) Branded pharmaceuticals sold through Drogasil and Raia pharmacies: line art illustration of faceless pharmacist behind a Drogasil pharmacy counter handing a medicine box to a customer
Drogasil pharmacy
Drogasil pharmacies sell mostly branded medicines.

The business makes money the way most retailers do: it buys products from drugmakers and consumer-goods companies, marks them up, and sells them to walk-in customers. What makes pharmacies special is that much of the demand is not optional. People need their blood-pressure pills and their baby's medicine whether the economy is booming or shrinking, which gives the business a steady, predictable feel. The chain also runs loyalty programs and its own app, and it has been pushing into higher-margin areas like generic drugs, private-label products, and beauty, where it can earn more per sale than on a plain box of aspirin. Scale is the whole game here. Because Raia Drogasil is so large, it can negotiate hard with suppliers, spread its costs across thousands of stores, and open new locations without straining its overhead. That has let it grow faster than most of the retail sector for years. Its main rivals are other big Brazilian chains, including Ultrapar, which owns the Extrafarma and Pague Menos-style pharmacy operations through its drugstore arm, though the competitive map keeps shifting as rivals merge and expand.


The company's big bet is simple: keep opening stores. It reinvests most of its profits into new locations and distribution centers rather than paying out fat dividends, on the theory that the Brazilian pharmacy market still has plenty of room to grow as the population ages and healthcare spending rises. That strategy has paid off in steady sales growth, but it also means the business is only as strong as its ability to keep finding good corners to open on β€” and to keep customers coming back through the door instead of clicking "buy" online.

Saved answer Β· last researched 12 Nov 2026